Clinical Trial Update: First-in-Human Trial of the A3-Shield System for Stabilizing Abdominal Aortic Aneurysms [NA]

View source ↗

Summary

First-in-human trial update for the A3-Shield System to stabilize abdominal aortic aneurysms; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Abdominal Aortic Aneurysm

Drugs mentioned

• A3-Shield System

Snippet

Sponsor: Angiolutions GmbH | Conditions: Aneurysm, Abdominal Aortic | NA | Status: RECRUITING